![Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age - eBioMedicine Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age - eBioMedicine](https://www.thelancet.com/cms/attachment/c52af90a-0ddf-4df4-a291-c43d78c83ff0/gr1_lrg.jpg)
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age - eBioMedicine
Slowly expanding lesions are a marker of progressive MS – No - Douglas L Arnold, Shibeshih Belachew, Arie R Gafson, Laura Gaetano, Corrado Bernasconi, Colm Elliott, 2021
![Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis - ScienceDirect Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572816301825-fx1.jpg)
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis - ScienceDirect
![Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis | Nature Reviews Neurology Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis | Nature Reviews Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41582-019-0170-8/MediaObjects/41582_2019_170_Fig1_HTML.png)
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis | Nature Reviews Neurology
![Thinking outside the box: non-canonical targets in multiple sclerosis | Nature Reviews Drug Discovery Thinking outside the box: non-canonical targets in multiple sclerosis | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-022-00477-5/MediaObjects/41573_2022_477_Fig1_HTML.png)
Thinking outside the box: non-canonical targets in multiple sclerosis | Nature Reviews Drug Discovery
![JCI Insight - Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function JCI Insight - Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function](https://df6sxcketz7bb.cloudfront.net/manuscripts/156000/156978/medium/jci.insight.156978.ga.jpg)
JCI Insight - Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
![The Role of Transcranial Magnetic Stimulation as a Surrogate Marker of Disease Activity in Patients with Multiple Sclerosis: A Literature Review - Innovations in Clinical Neuroscience : Innovations in Clinical Neuroscience The Role of Transcranial Magnetic Stimulation as a Surrogate Marker of Disease Activity in Patients with Multiple Sclerosis: A Literature Review - Innovations in Clinical Neuroscience : Innovations in Clinical Neuroscience](https://innovationscns.com/wp-content/uploads/ICNSJan-Mar22_Bashir_Image.jpg)